TNX-1500

N/A

Report date: 2026/03/17 20:00:15

Base Information

Drug NameTNX-1500
Drug Alias NameAnti-CD154 monoclonal antibodyAntiCD40 ligand antibodyFc-modified humanized anti-CD40L mAbFc-modified humanized anti-CD40L monoclonal antibodyTNX-1500
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCD40 ligand inhibitors
TargetsCD40 ligand
Therapy Area/IndicationsRejection of organ transplantationRejection of renal transplantationAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTonix Pharmaceuticals Holding Corp
China Registration ClassN/A

Develop Information

Active CompaniesMakana Therapeutics IncTonix Pharmaceuticals Holding CorpTonix Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationRejection of renal transplantationAutoimmune Diseases
Inactive IndicationsAutoimmune Diseases of the Nervous System

Other Information

ATC CodeN/A
Related LinksN/A